Janux Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$28.82(as of Nov 21, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Janux Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$28.82
Ticker SymbolJANX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees109
CountyUSA
Market Cap$1,732.3M
EBIDTA-142.2M
10-Day Moving Average28.57
P/E Ratio-17.53
20-Day Moving Average28.24
Forward P/E Ratio0.00
50-Day Moving Average26.05
Earnings per Share-1.67
200-Day Moving Average26.95
Profit Margin-243.13%
RSI55.44
Shares Outstanding60.1M
ATR1.88
52-Week High71.71
Volume795,900
52-Week Low21.73
Most Recent Support Level28.25
Book Value976.6M
Most Recent Resistance Level30.23
P/B Ratio1.83
Upper Keltner32.48
P/S Ratio1,200.46
Lower Keltner24.01
Debt-to-Equity Ratio32.48
Next Earnings Date03/06/2026
Cash Surplus20.6M
Next Ex-Dividend DateUnknown

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer. Its clinical candidates include JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor that is in Phase 1 clinical trial for the treatment of various solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, renal cell carcinoma, small cell lung cancer, pancreatic ductal adenocarcinoma, and triple-negative breast cancer. Janux Therapeutics, Inc. has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. The company was incorporated in 2017 and is headquartered in San Diego, California.

Janux Therapeutics Inc In Our Stock Scanner

As of Nov 24, 2025
example chart graphic
Scan Name: Ascending TriangleScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.